KCM
MDT icon

Kathmere Capital Management’s Medtronic MDT Stock Holding History

Kathmere Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$309K Sell
3,953
-5,010
-56% -$404K 0.02% 517
2026
Q1 		$777K Sell
8,963
-2,345
-21% -$225K 0.05% 264
2025
Q4 		$1.09M Sell
11,308
-1,498
-12% -$146K 0.07% 175
2025
Q3 		$1.22M Buy
12,806
+5,034
+65% +$463K 0.09% 151
2025
Q2 		$677K Buy
7,772
+1,788
+30% +$152K 0.05% 224
2025
Q1 		$538K Buy
5,984
+2,343
+64% +$210K 0.05% 234
2024
Q4 		$291K Buy
+3,641
New +$315K 0.03% 317

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Kathmere Capital Management's MDT Position: Q2 2026 in Review

Kathmere Capital Management reduced its Medtronic (MDT) stake by 56% in Q2 2026, selling an estimated $404K and leaving 3,953 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #517.

Kathmere Capital Management first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.22M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Kathmere Capital Management held 3,953 shares of Medtronic worth $309K as of Q2 2026.
  • Kathmere Capital Management sold 5,010 Medtronic shares in Q2 2026, an estimated $404K.
  • Medtronic made up 0.02% of Kathmere Capital Management's portfolio in Q2 2026, its #517 holding.
  • Kathmere Capital Management first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Kathmere Capital Management's Medtronic position peaked at $1.22M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.